10-Q: PreAxia Health Care Q3 2026 Financials Show Growing Expenses

PreAxia Health Care Payment Systems Inc. reports increased expenses and a continued net loss for the nine months ended February 28, 2026, while focusing on product development and capital raising.

Summary

• PreAxia Health Care Payment Systems Inc. filed its quarterly report for the period ending February 28, 2026.
• The company reported zero revenue for both the three and nine-month periods ended February 28, 2026, and 2025.
• Total expenses for the three months ended February 28, 2026, were $94,659, an increase from $13,463 in the prior year period.
• Total expenses for the nine months ended February 28, 2026, were $782,848, a significant increase from $31,756 in the prior year period.
• The net loss for the nine months ended February 28, 2026, was $951,362, compared to a net loss of $31,756 for the same period in 2025.
• The company's cash balance was $57,330 as of February 28, 2026.
• PreAxia has a working capital deficit of $749,501 as of February 28, 2026.
• The company plans to raise approximately $1,000,000 over the next twelve months to fund operations and execute its business plan.
• The company is developing personal financial management applications and health care payment processing services through its subsidiaries Zane Inc. CA and Zane Inc. US.
• Management has concluded that the company's ability to continue as a going concern is dependent on its ability to secure additional capital and achieve profitable operations.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the complete lack of revenue, significantly increased expenses, a widening net loss, and substantial doubt expressed by management regarding the company's ability to continue as a going concern.

Positives

• The company's cash balance increased to $57,330 from $0 as of May 31, 2025.
• The working capital deficit improved significantly, decreasing from ($2,341,169) as of May 31, 2025, to ($749,501) as of February 28, 2026.
• Significant progress has been made in capitalizing software development costs, with $385,450 capitalized as of February 28, 2026.
• The company has established subsidiaries in Canada and the US to focus on product development and market penetration.
• Subsequent to the period end, on March 9, 2026, the company sold 200,000 shares of common stock for $50,000 in cash.

Negatives

• The company reported zero revenue for both the three and nine-month periods.
• Total expenses increased substantially, from $13,463 to $94,659 for the three-month period and from $31,756 to $782,848 for the nine-month period.
• The net loss widened significantly to $951,362 for the nine months ended February 28, 2026, from $31,756 in the prior year.
• The company has a substantial working capital deficit of $749,501.
• Management has identified substantial doubt about the company's ability to continue as a going concern.
• The company's disclosure controls and procedures were found to be not effective as of February 28, 2026.

Risks

• The company's ability to continue as a going concern is dependent on its ability to raise additional capital and achieve profitable operations.
• There is no assurance that the company will be able to obtain the necessary financing on commercially reasonable terms or at all.
• Failure to obtain additional financing could force the company to scale down or cease operations.
• The company's products are still in the development stage, and there is no guarantee of market acceptance or successful commercialization.
• The company faces competition in the health care payment processing and personal financial management sectors.
• The company's future success depends on its ability to attract and retain qualified personnel, including senior management, sales, and engineering positions.
• The company's disclosure controls and procedures were not effective as of February 28, 2026, which could lead to misstatements or omissions in future filings.

Future Outlook

The company plans to raise additional capital to fund its operations and execute its business plans over the next twelve months. This includes filling senior management, sales, administrative, and engineering positions, developing personal financial management applications, penetrating markets in Canada, the United States, and worldwide with financial and health care products, and building strategic alliances with employers, health insurance companies, and governments.

Management Comments

• Management believes that all adjustments necessary for a fair presentation of the financial position and results of operations have been included in the unaudited condensed consolidated financial statements.
• Management has concluded that there are substantial doubts about the Company's ability to continue as a going concern within one year of the date that the consolidated financial statements are issued.
• Management believes that there are no current legal matters that would have a material effect on the Company's financial position or results of operations.

Industry Context

StockSavvy.ai notes that PreAxia Health Care Payment Systems Inc. is operating in the evolving health care payment processing and personal financial management sectors. The company highlights the growing trend towards self-directed health payment systems and the increasing demand for convenient benefit services, citing the growth of Health Savings Accounts (HSAs) in the US and the Canadian group insurance industry as indicators of market opportunity. The company's strategy to develop an AI-powered personal financial management super-app, termed a 'personal AI-banker in your pocket,' aligns with broader fintech trends focused on personalized financial guidance and automated money management.

Comparison to Industry Standards

• The company's reported zero revenue for the period is significantly below industry standards for established health care payment processing or financial management companies, which typically generate substantial revenue from transaction fees, subscriptions, or service charges.
• The significant increase in operating expenses ($782,848 for nine months ended Feb 28, 2026) without corresponding revenue generation is a concern when compared to industry benchmarks where expense growth is usually tied to revenue expansion or strategic investments with clear ROI projections.
• The company's reliance on future capital raises to fund operations and development is a common characteristic of early-stage technology companies but contrasts with more mature companies that are self-sustaining or generate positive cash flow from operations.
• The development of an AI-powered 'personal AI-banker' is an ambitious undertaking. While many fintech companies are investing in AI, the specific features like a 'High-Interest Super Account (HISA)' promising 10% APY, a 'Smart Debit Card' that makes overspending impossible, and a 'MoneyNet' distributed network are innovative but require significant technological development and regulatory compliance, which are benchmarks for success in the fintech space.

Corporate Governance

Legal Proceedings

• Management believes there are no current material legal proceedings pending against the company or its subsidiary, nor any contemplated by governmental authorities.

Related Party Transactions

• Accruals and other current liabilities include accrued officer compensation and related payroll taxes for Tom Zapatinas ($480,000) and INARE ($15,931) as of February 28, 2026.
• Related party loans include advances payable to Tom Zapatinas totaling $82,242 as of February 28, 2026.
• Convertible promissory notes and convertible notes payable to Tom Zapatinas were converted to stock subscriptions on June 30, 2025.

Stakeholder Impact

• Shareholders: Potential for significant dilution if future capital raises are equity-based; current lack of revenue and net loss may impact stock value.
• Employees: Need for hiring senior management, sales, administrative, and engineering positions indicates potential for new job opportunities.
• Creditors: The company requires $300,000 to pay arms-length creditors, indicating a need for timely payment to maintain supplier relationships.
• Management: Officers are committed to making advances or loans to cover certain costs, indicating personal financial commitment.

Next Steps

• Raise additional capital to execute business plans.
• Fill senior management, sales, administrative, and engineering positions.
• Develop state-of-the-art personal financial management applications.
• Penetrate markets in Canada, the United States, and worldwide with financial and health care products and services.
• Build a network of strategic alliances with large employers, health insurance companies, governments, and other entities.

Key Dates

Recommendation

The company exhibits critical financial distress with zero revenue, escalating losses, and substantial doubt about its going concern status. The significant increase in expenses without revenue generation, coupled with ineffective disclosure controls, presents a high-risk investment profile. While plans for capital raises and product development exist, the immediate financial precariousness and lack of commercial traction warrant a sell recommendation.

Keywords

PreAxia Health Care, Form 10-Q, Quarterly Report, Financial Statements, Net Loss, Revenue, Expenses, Going Concern, Capital Raise, Software Development, Personal Financial Management, Health Care Payment Processing, Nevada, SEC Filing